Why Aerpio Shares Are Skyrocketing Today
Why Aerpio Shares Are Skyrocketing Today
Shares of microcap biopharma Aerpio Pharmaceuticals, Inc. (ARPO) are advancing strongly Thursday on above-average volume.
微盘生物制药股份Aerpio制药公司(ARPO)周四以高于平均水平的成交量强劲推进。
The upside in reaction a positive analyst action. H.C. Wainwright analyst Robert Burns upgraded Aerpio from Neutral to Buy and instituted a post-merger price target of $22 per share.
反应中的利好因素是分析师的积极行动。H.C.Wainwright分析师罗伯特·伯恩斯(Robert Burns)将Aerpio的评级从中性上调至买入，并设定了合并后每股22美元的目标价。
Aerpio announced a reverse merger transaction in May under which it will combine with privately-held Aadi Bioscience. Following the merger, Aerpio will change its name to Aadi Bioscience and trade on the Nasdaq under the ticker symbol AADI. The combined company will focus on advancing Aadi's lead product candidate FYARRO.
Aerpio在5月份宣布了一项反向合并交易，根据该交易，它将与私人持股的Aadi Bioscience合并。合并后，Aerpio将更名为Aadi Bioscience，并在纳斯达克上以AADI的股票代码进行交易。合并后的公司将专注于推进AADI的主要候选产品FYARRO。
Related Link: 14 Biotech Stocks To Watch Over The Next 6 Months
相关链接：未来6个月关注的14只生物科技股
The Aadi Bioscience transaction appears transformative, allowing rapid advancement in oncology, Burns said in the upgrade.
伯恩斯在升级中说，Aadi Bioscience交易似乎具有变革性，允许肿瘤学的快速发展。
In a Schedule 14A filing with the SEC, Aerpio has scheduled a special meeting of shareholders at 10 am on Aug. 17, wherein shareholders will be asked to vote on certain proposals necessary for the consummation of the transaction.
在提交给美国证券交易委员会的附表14A文件中，Aerpio计划在8月17日上午10点召开特别股东大会，会上股东将被要求就完成交易所需的某些提案进行投票。
Aerpio also said its board has unanimously approved the transaction.
Aerpio还表示，其董事会已一致批准了这笔交易。
At last check, Aerpio shares were soaring 61.4% at $2.76.
据最新消息，Aerpio股价飙升61.4%，至2.76美元。
译文内容由第三方软件翻译。